1.A comparison of the performance of SVEAT score versus HEART score in predicting in-hospital MACE in patients admitted for chest pain
Philippine Journal of Internal Medicine 2025;63(3):5-15
BACKGROUND
Chest pain is a common reason for emergency room visits. The HEART score is used as a risk stratification tool to aid in clinical decision making. The HEART score is a useful tool due to its good sensitivity, however it has low specificity. The SVEAT score was developed as an improved risk stratification tool which outperformed the HEART score in previous studies. Both the performance of HEART and SVEAT scores lack data in our locality.
OBJECTIVETo compare the performance of Symptoms, Vascular disease, Electrocardiography, Age, Troponin-I (SVEAT) score and History, Electrocardiography, Age, Risk factors, Troponin-I (HEART) score as predictors of in-hospital Major Adverse Cardiovascular Events (MACE) among adult patients admitted in Chong Hua Hospital Cebu for chest pain.
METHODSThis single-center, retrospective, observational analytic study included adult patients, ages 18 years old and above, who were admitted for chest pain from January 1, 2022 to December 31, 2022. All patients who passed the inclusion and exclusion criteria were included in the data analysis. Both SVEAT and HEART scores were calculated for each of the included subjects. The performance of both scoring criteria was compared using logistic regression and area under the receiving-operator characteristic curve.
RESULTSA total of 113 cases were analyzed after exclusion criteria were applied. A total of 50 (44.2%) individuals suffered MACE. The difference in AUC of both SVEAT (0.946, 95%CI) and HEART (0.936, 95%CI) was not statistically significant (95% CI – 0.013 – 0.033, p = 0.400). With a cut-off ofCONCLUSION
SVEAT and HEART scores had similar performance in predicting in hospital MACE. Using a cut-off value of
Human
;
Chest Pain
;
Heart
;
Myocardial Infarction
;
Acute Coronary Syndrome
2.Machine learning to risk stratify chest pain patients with non-diagnostic electrocardiogram in an Asian emergency department.
Ziwei LIN ; Tar Choon AW ; Laurel JACKSON ; Cheryl Shumin KOW ; Gillian MURTAGH ; Siang Jin Terrance CHUA ; Arthur Mark RICHARDS ; Swee Han LIM
Annals of the Academy of Medicine, Singapore 2025;54(4):219-226
INTRODUCTION:
Elevated troponin, while essential for diagnosing myocardial infarction, can also be present in non-myocardial infarction conditions. The myocardial-ischaemic-injury-index (MI3) algorithm is a machine learning algorithm that considers age, sex and cardiac troponin I (TnI) results to risk-stratify patients for type 1 myocardial infarction.
METHOD:
Patients aged ≥25 years who presented to the emergency department (ED) of Singapore General Hospital with symptoms suggestive of acute coronary syndrome with no diagnostic 12-lead electrocardiogram (ECG) changes were included. Participants had serial ECGs and high-sensitivity troponin assays performed at 0, 2 and 7 hours. The primary outcome was the adjudicated diagnosis of type 1 myocardial infarction at 30 days. We compared the performance of MI3 in predicting the primary outcome with the European Society of Cardiology (ESC) 0/2-hour algorithm as well as the 99th percentile upper reference limit (URL) for TnI.
RESULTS:
There were 1351 patients included (66.7% male, mean age 56 years), 902 (66.8%) of whom had only 0-hour troponin results and 449 (33.2%) with serial (both 0 and 2-hour) troponin results available. MI3 ruled out type 1 myocardial infarction with a higher sensitivity (98.9, 95% confidence interval [CI] 93.4-99.9%) and similar negative predictive value (NPV) 99.8% (95% CI 98.6-100%) as compared to the ESC strategy. The 99th percentile cut-off strategy had the lowest sensitivity, specificity, positive predictive value and NPV.
CONCLUSION
The MI3 algorithm was accurate in risk stratifying ED patients for myocardial infarction. The 99th percentile URL cut-off was the least accurate in ruling in and out myocardial infarction compared to the other strategies.
Humans
;
Male
;
Female
;
Emergency Service, Hospital
;
Middle Aged
;
Electrocardiography
;
Machine Learning
;
Singapore
;
Chest Pain/blood*
;
Troponin I/blood*
;
Myocardial Infarction/blood*
;
Risk Assessment/methods*
;
Aged
;
Algorithms
;
Acute Coronary Syndrome/blood*
;
Adult
;
Sensitivity and Specificity
3.Exploring the Feasibility of Machine Learning to Predict Risk Stratification Within 3 Months in Chest Pain Patients with Suspected NSTE-ACS.
Zhi Chang ZHENG ; Wei YUAN ; Nian WANG ; Bo JIANG ; Chun Peng MA ; Hui AI ; Xiao WANG ; Shao Ping NIE
Biomedical and Environmental Sciences 2023;36(7):625-634
OBJECTIVE:
We aimed to assess the feasibility and superiority of machine learning (ML) methods to predict the risk of Major Adverse Cardiovascular Events (MACEs) in chest pain patients with NSTE-ACS.
METHODS:
Enrolled chest pain patients were from two centers, Beijing Anzhen Emergency Chest Pain Center Beijing Bo'ai Hospital, China Rehabilitation Research Center. Five classifiers were used to develop ML models. Accuracy, Precision, Recall, F-Measure and AUC were used to assess the model performance and prediction effect compared with HEART risk scoring system. Ultimately, ML model constructed by Naïve Bayes was employed to predict the occurrence of MACEs.
RESULTS:
According to learning metrics, ML models constructed by different classifiers were superior over HEART (History, ECG, Age, Risk factors, & Troponin) scoring system when predicting acute myocardial infarction (AMI) and all-cause death. However, according to ROC curves and AUC, ML model constructed by different classifiers performed better than HEART scoring system only in prediction for AMI. Among the five ML algorithms, Linear support vector machine (SVC), Naïve Bayes and Logistic regression classifiers stood out with all Accuracy, Precision, Recall and F-Measure from 0.8 to 1.0 for predicting any event, AMI, revascularization and all-cause death ( vs. HEART ≤ 0.78), with AUC from 0.88 to 0.98 for predicting any event, AMI and revascularization ( vs. HEART ≤ 0.85). ML model developed by Naïve Bayes predicted that suspected acute coronary syndrome (ACS), abnormal electrocardiogram (ECG), elevated hs-cTn I, sex and smoking were risk factors of MACEs.
CONCLUSION
Compared with HEART risk scoring system, the superiority of ML method was demonstrated when employing Linear SVC classifier, Naïve Bayes and Logistic. ML method could be a promising method to predict MACEs in chest pain patients with NSTE-ACS.
Humans
;
Acute Coronary Syndrome/epidemiology*
;
Bayes Theorem
;
Feasibility Studies
;
Risk Assessment/methods*
;
Chest Pain/etiology*
;
Myocardial Infarction/diagnosis*
4.Progress in Gene Therapy of Sickle Cell Disease Based on Hemoglobin F--Review.
Hao LIANG ; Yun-Xia WANG ; Xu-Yan LI ; Ya-Qi WANG ; Yan SU
Journal of Experimental Hematology 2021;29(2):643-647
Sickle cell disease (SCD) is a single gene genetic disease, which seriously threatens the life span and quality of patients. On the basis of the pathogenesis of SCD and the alternative therapy based on fetal hemoglobin F (HbF), the research progress of transcription factors involved in the regulation of HbF gene expression, such as BCL11A, ZBTB7A, KLF-1, c-MYB and SOX6, as well as the application of CRISPR / Cas9, TALEN, zinc finger nuclease and other gene editing technologies in this field has been made, providing a solid theoretical basis for the exploration of new treatment schemes for β- like hemoglobin diseases, such as sickle cell disease and β- thalassemia.
Anemia, Sickle Cell/therapy*
;
Cell Line, Tumor
;
DNA-Binding Proteins
;
Fetal Hemoglobin/genetics*
;
Genetic Therapy
;
Humans
;
Repressor Proteins/genetics*
;
Transcription Factors
5.BCL11A rs1427407 Genotypes in Sickle Cell Anemia Patients Undergo to Stroke Problems in Sudan.
Fathelrahman Mahdi HASSAN ; Faisal Mousa AL-ZAHRANI
Korean Journal of Family Medicine 2019;40(1):53-57
BACKGROUND: Sickle cell disease is an autosomal recessive condition that results from the presence of a mutated form of hemoglobin. Some genetic variants of BCL11A are amenable to therapeutic manipulation. The present study investigated the relationship of a BCL11A variant (rs1427407) and its plasma levels with vaso-occlusive crises and stroke complications among patients in Sudan with sickle cell disease. METHODS: This cross-sectional study was performed between June 2014 and October 2016. The subjects included 166 patients who were diagnosed with sickle cell disease and 35 healthy control subjects, who were grouped according to sex and age ( < 15 years, 15–25 years, and >25 years). All patients and/or their guardians provided informed consent. Blood samples were collected from the patients and controls under aseptic conditions. RESULTS: Plasma BCL11A levels were elevated in cases with vaso-occlusive crises that lasted for >3 years. In addition, plasma BCL11A levels were high in cases with the GG genotype (vs. GT and TT) at rs1427407. Furthermore, the BCL11A rs1427407 GG/GT genotypes increased the risk of vaso-occlusive crisis and stroke in the patients with sickle cell disease. CONCLUSION: The BCL11A variant (rs1427407) and its plasma levels were associated with vaso-occlusive crisis and stroke in patients with sickle cell disease.
Anemia, Sickle Cell*
;
Cross-Sectional Studies
;
Genotype*
;
Humans
;
Informed Consent
;
Plasma
;
Stroke*
;
Sudan*
6.Microcytosis in children and adolescents with the sickle cell trait in Basra, Iraq
Rawshan Zuhair JABER ; Meàad Kadhum HASSAN ; Sadeq Khalaf AL-SALAIT
Blood Research 2019;54(1):38-44
BACKGROUND: Microcytic anemia, the most common form of anemia in children and adolescents, is a heterogeneous group of diseases that is acquired or inherited. We assessed the frequency and causes of microcytosis in children and adolescents with the sickle cell trait (SCT). METHODS: This descriptive study included 95 subjects (49 males and 46 females) with SCT who attended Basra Center for Hereditary Blood Diseases for evaluation. Investigations included complete blood count, high performance liquid chromatography, capillary electrophoresis, and measurement of serum ferritin and transferrin levels. RESULTS: SCT subjects had a low hemoglobin (Hb) concentration (9.79±1.75 g/dL), low mean corpuscular volume (MCV, 67.43±9.22), low mean corpuscular Hb (21.15±3.64), and a normal red cell distribution width (RDW, 14.00±2.30). Among 95 SCT subjects, 81 (85.26%) had microcytosis, 12 (12.63%) had normal MCV, and 2 (2.11%) exhibited macrocytosis. Sixty-three (77.78%) SCT subjects with microcytosis were iron deficient, and 18 (22.22%) had normal iron levels. The mean serum ferritin and HbA2 levels were significantly lower, while the RDW, sickle Hb, and serum transferrin levels were significantly higher in patients with microcytosis and iron deficiency compared to non-iron deficient subjects (P<0.05). Correlation coefficients did not reveal a significant association between the MCV and iron status of SCT subjects (P>0.05). CONCLUSION: Despite the frequent occurrence of iron deficiency in SCT subjects, co-inheritance of alpha-thalassemia seemed to be the cause of low MCV in non-iron deficient individuals with microcytosis. Genetic analysis is required to understand the genetic basis of this phenomenon.
Adolescent
;
alpha-Thalassemia
;
Anemia
;
Blood Cell Count
;
Child
;
Chromatography, Liquid
;
Electrophoresis, Capillary
;
Erythrocyte Indices
;
Ferritins
;
Hematologic Diseases
;
Humans
;
Iraq
;
Iron
;
Male
;
Sickle Cell Trait
;
Transferrin
7.Biochemical effects and safety of Gum arabic (Acacia Senegal) supplementation in patients with sickle cell anemia
Lamis AbdelGadir KADDAM ; Imad FDL-ELMULA ; Omer Ali EISAWI ; Haydar Awad ABDELRAZIG ; Mustafa Khidir ELNIMEIRI ; Amal Mahmoud SAEED
Blood Research 2019;54(1):31-37
BACKGROUND: Sickle cell anemia (SCA) is a hereditary chronic hemolytic anemia with several clinical consequences. Intravascular sickling of red blood cells leads to multi-organ dysfunction. Moreover, several biochemical abnormalities have been associated with SCA. Gum arabic (GA) is an edible dried gummy exudate obtained from Acacia Senegal tree. GA showed antioxidant and cytoprotective activities and demonstrated protection against hepatic, renal, and cardiac toxicities in experimental rats. We hypothesized that regular intake of GA improves renal and liver functions in patients with SCA. METHODS: Forty-seven patients (5–42 yr) carrying hemoglobin SS were recruited. The patients received 30 g/day GA for 12 weeks. Blood samples were collected before administering GA and then after 4, 8, and 12 weeks. Liver enzymes, total protein, albumin, electrolytes, urea, creatinine, and uric acid were determined in the serum. The study was approved by the Al Neelain University Institutional Review Board and Research Ethics Committee Ministry of Health. The trial was registered at ClinicalTrials.gov (identifier: NCT02467257). RESULTS: GA significantly decreased direct bilirubin level [statistical significance (P-value)=0.04]. It also significantly decreased serum alanine transaminase level after 4 weeks, which was sustained till the 8th week. GA, however, had no effect on serum aspartate transaminase level. In terms of renal function, GA decreased serum urea level but the effect was not sustained after the first month. CONCLUSION: GA may alter the disease severity in SCA as demonstrated by its ability to decrease direct bilirubin and urea levels in the serum.
Acacia
;
Alanine Transaminase
;
Anemia, Hemolytic
;
Anemia, Sickle Cell
;
Animals
;
Aspartate Aminotransferases
;
Bilirubin
;
Cardiotoxicity
;
Creatinine
;
Electrolytes
;
Erythrocytes
;
Ethics Committees, Research
;
Exudates and Transudates
;
Gingiva
;
Gum Arabic
;
Hemoglobin, Sickle
;
Humans
;
Liver
;
Rats
;
Senegal
;
Trees
;
Urea
;
Uric Acid
8.Multicenter observational study on the reliability of the HEART score
Nicola PARENTI ; Giuseppe LIPPI ; Maria Letizia BACCHI REGGIANI ; Antonio LUCIANI ; Mario CAVAZZA ; Antonello PIETRANGELO ; Alberto VEGETTI ; Lucio BRUGIONI ; Laura BONFANTI ; Gianfranco CERVELLIN
Clinical and Experimental Emergency Medicine 2019;6(3):212-217
OBJECTIVE: To rapidly and safely identify the risk of developing acute coronary syndrome in patients with chest pain who present to the emergency department, the clinical use of the History, Electrocardiogram, Age, Risk Factors, and Troponin (HEART) scoring has recently been proposed. This study aimed to assess the inter-rater reliability of the HEART score calculated by a large number of Italian emergency physicians.METHODS: The study was conducted in three academic emergency departments using clinical scenarios obtained from medical records of patients with chest pain. Twenty physicians, who took the HEART score course, independently assigned a score to different clinical scenarios, which were randomly administered to the participants, and data were collected and recorded in a spreadsheet by an independent investigator who was blinded to the study’s aim.RESULTS: After applying the exclusion criteria, 53 scenarios were finally included in the analysis. The general inter-rater reliability was good (kappa statistics [κ], 0.63; 95% confidence interval, 0.57 to 0.70), and a good inter-rater agreement for the high- and low-risk classes (HEART score, 7 to 10 and 0 to 3, respectively; κ, 0.60 to 0.73) was observed, whereas a moderate agreement was found for the intermediate-risk class (HEART score, 4 to 6; κ, 0.51). Among the different items of the HEART score, history and electrocardiogram had the worse agreement (κ, 0.37 and 0.42, respectively).CONCLUSION: The HEART score had good inter-rater reliability, particularly among the high- and low-risk classes. The modest agreement for history suggests that major improvements are needed for objectively assessing this component.
Acute Coronary Syndrome
;
Chest Pain
;
Electrocardiography
;
Emergencies
;
Emergency Service, Hospital
;
Heart
;
Humans
;
Medical Records
;
Observational Study
;
Research Personnel
;
Risk Factors
;
Troponin
9.Potential impact of cardiology phone-consultation for patients risk-stratified by the HEART pathway
Ken MONAHAN ; Margaret PAN ; Chinonso OPARA ; Maame Yaa A B YIADOM ; Daniel MUNOZ ; Benjamin B HOLMES ; Davis STEPHEN ; Kristopher J SWIGER ; Sean P COLLINS
Clinical and Experimental Emergency Medicine 2019;6(3):196-203
OBJECTIVE: Bedside consultation by cardiologists may facilitate safe discharge of selected patients from the emergency department (ED) even when admission is recommended by the History, Electrocardiogram, Age, Risk factors, Troponin (HEART) pathway. If bedside evaluation is unavailable, phone consultation between emergency physicians and cardiologists would be most impactful if the resultant disposition is discordant with the HEART pathway. We therefore evaluate discordance between actual disposition and that suggested by the HEART pathway in patients presenting to the ED with chest pain for whom cardiology consultation occurred exclusively by phone and to assess the impact of phone-consultation on disposition.METHODS: We performed a single-center, retrospective study of adults presenting to the ED with chest pain whose emergency physician had a phone consultation with a cardiologist. Actual disposition was abstracted from the medical record. HEART pathway category (low-risk, discharge; high-risk, admit) was derived from ED documentation. For discharged patients, major adverse cardiac events were assessed at 30 days by chart review and phone follow-up.RESULTS: For the 170 patients that had cardiologist phone consultation, discordance between actual disposition and the HEART pathway was 17%. The HEART pathway recommended admission for nearly 80% of discharged patients. Following cardiologist phone-consultation, 10% of high-risk patients were discharged, with the majority having undergone a functional study recommended by the cardiologist. At 30 days, discharged patients had experienced no episodes of major adverse cardiac events or rehospitalization for cardiac reasons.CONCLUSION: For patients presenting to the ED with chest pain, cardiology phone-consultation has the potential to safely impact disposition, primarily by facilitating functional testing in high-risk individuals.
Acute Coronary Syndrome
;
Adult
;
Cardiology
;
Chest Pain
;
Electrocardiography
;
Emergencies
;
Emergency Service, Hospital
;
Follow-Up Studies
;
Heart
;
Humans
;
Medical Records
;
Retrospective Studies
;
Risk Factors
;
Troponin
10.A Case of Zaltoprofen Induced Kounis Syndrome
Seong You LEE ; Won Young SUNG ; Jang Young LEE ; Sang Won SEO ; Won Suk LEE
Journal of The Korean Society of Clinical Toxicology 2019;17(1):32-37
Kounis syndrome is defined as the occurrence of acute coronary syndrome associated with vasoactive mediators, such as histamines in the setting of hypersensitivity and allergic reactions or anaphylactic insults. The condition can be caused by various drugs, foods, or environmental factors that cause allergic reactions. A 35-year-old male visited the emergency room with anaphylaxis accompanied by chest pain approximately 20 minutes after taking zaltoprofen, a nonsteroidal anti-inflammatory drug. After acute treatment for the anaphylaxis, the patient was stabilized and all symptoms disappeared, but the ischemic changes in the electrocardiogram and elevation of the cardiac enzymes were observed. The emergency cardiac angiography and echocardiography were all normal. The allergic reaction of this patient to zaltoprofen was believed to cause a temporary coronary arterial vasospasm, inducing Type 1 Kounis syndrome. Thus far, there have been case reports of Kounis syndrome caused by a range of nonsteroidal anti-inflammatory drugs, but there are no reports of the condition being caused by zaltoprofen. According to the pathophysiology, both cardiac and allergic symptoms must be solved simultaneously, so rapid treatment and diagnosis are needed. Doctors treating acute allergic reactions and anaphylaxis patients must check the cardiovascular symptoms thoroughly and consider the possibility of Kounis syndrome.
Acute Coronary Syndrome
;
Adult
;
Anaphylaxis
;
Angiography
;
Chest Pain
;
Diagnosis
;
Echocardiography
;
Electrocardiography
;
Emergencies
;
Emergency Service, Hospital
;
Humans
;
Hypersensitivity
;
Male


Result Analysis
Print
Save
E-mail